v3.26.1
Unaudited Condensed Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Total
Class A common stock
Class B convertible common stock
Common Stock
Class A common stock
Common Stock
Class B convertible common stock
Additional paid-in capital
Retained earnings (Accumulated deficit)
Accumulated other comprehensive loss
Treasury stock
Beginning balance (in shares) at Dec. 31, 2024       33,215,441 70,032,694        
Beginning balance at Dec. 31, 2024 $ 496,919     $ 332 $ 700 $ 726,917 $ (44,114) $ (25,389) $ (161,527)
Beginning balance (in shares) at Dec. 31, 2024                 13,323,977
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for settlement of equity awards (in shares)       1,237,630          
Issuance of common stock for settlement of equity awards 218     $ 12   206      
Shares withheld related to net share settlement (in shares)       (376,750)          
Shares withheld related to net share settlement (5,114)     $ (3)   (5,111)      
Repurchase of common stock (in shares)                 750,691
Repurchase of common stock (10,107)               $ (10,107)
Stock-based compensation expense 8,749         8,749      
Net income 21,148           21,148    
Other comprehensive income (loss) 8,498             8,498  
Ending balance (in shares) at Mar. 31, 2025       34,076,321 70,032,694        
Ending balance at Mar. 31, 2025 520,311     $ 341 $ 700 730,761 (22,966) (16,891) $ (171,634)
Ending balance (in shares) at Mar. 31, 2025                 14,074,668
Beginning balance (in shares) at Dec. 31, 2024       33,215,441 70,032,694        
Beginning balance at Dec. 31, 2024 496,919     $ 332 $ 700 726,917 (44,114) (25,389) $ (161,527)
Beginning balance (in shares) at Dec. 31, 2024                 13,323,977
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 41,195                
Other comprehensive income (loss) 15,972                
Ending balance (in shares) at Jun. 30, 2025       50,149,749 55,032,694        
Ending balance at Jun. 30, 2025 544,550     $ 501 $ 550 745,144 (2,919) (9,417) $ (189,309)
Ending balance (in shares) at Jun. 30, 2025                 15,436,224
Beginning balance (in shares) at Mar. 31, 2025       34,076,321 70,032,694        
Beginning balance at Mar. 31, 2025 520,311     $ 341 $ 700 730,761 (22,966) (16,891) $ (171,634)
Beginning balance (in shares) at Mar. 31, 2025                 14,074,668
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for settlement of equity awards (in shares)       1,126,778          
Issuance of common stock for settlement of equity awards 6,909     $ 11   6,898      
Shares withheld related to net share settlement (in shares)       (53,350)          
Shares withheld related to net share settlement (823)     $ (1)   (822)      
Conversion of common stock (in shares)       15,000,000 (15,000,000)        
Conversion of common stock       $ 150 $ (150)        
Repurchase of common stock (in shares)                 1,361,556
Repurchase of common stock (17,675)               $ (17,675)
Stock-based compensation expense 8,307         8,307      
Net income 20,047           20,047    
Other comprehensive income (loss) 7,474             7,474  
Ending balance (in shares) at Jun. 30, 2025       50,149,749 55,032,694        
Ending balance at Jun. 30, 2025 544,550     $ 501 $ 550 745,144 (2,919) (9,417) $ (189,309)
Ending balance (in shares) at Jun. 30, 2025                 15,436,224
Beginning balance (in shares) at Dec. 31, 2025   35,463,015 55,032,694 50,899,239 55,032,694        
Beginning balance at Dec. 31, 2025 $ 599,989     $ 509 $ 550 754,773 58,161 (24,695) $ (189,309)
Beginning balance (in shares) at Dec. 31, 2025 15,436,224               15,436,224
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for settlement of equity awards (in shares)       1,527,138          
Issuance of common stock for settlement of equity awards $ 78     $ 15   63      
Shares withheld related to net share settlement (in shares)       (475,988)          
Shares withheld related to net share settlement (4,417)     $ (4)   (4,413)      
Stock-based compensation expense 5,210         5,210      
Reclassification of liability-portion of awards (6,687)         (6,687)      
Distribution of dividends (332,788)           (332,788)    
Net income 24,332           24,332    
Other comprehensive income (loss) (10,752)             (10,752)  
Ending balance (in shares) at Mar. 31, 2026       51,950,389 55,032,694        
Ending balance at Mar. 31, 2026 274,965     $ 520 $ 550 748,946 (250,295) (35,447) $ (189,309)
Ending balance (in shares) at Mar. 31, 2026                 15,436,224
Beginning balance (in shares) at Dec. 31, 2025   35,463,015 55,032,694 50,899,239 55,032,694        
Beginning balance at Dec. 31, 2025 $ 599,989     $ 509 $ 550 754,773 58,161 (24,695) $ (189,309)
Beginning balance (in shares) at Dec. 31, 2025 15,436,224               15,436,224
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income $ 46,301                
Other comprehensive income (loss) (10,837)                
Ending balance (in shares) at Jun. 30, 2026   36,646,204 55,032,694 52,082,428 55,032,694        
Ending balance at Jun. 30, 2026 $ 299,845     $ 521 $ 550 751,941 (228,326) (35,532) $ (189,309)
Ending balance (in shares) at Jun. 30, 2026 15,436,224               15,436,224
Beginning balance (in shares) at Mar. 31, 2026       51,950,389 55,032,694        
Beginning balance at Mar. 31, 2026 $ 274,965     $ 520 $ 550 748,946 (250,295) (35,447) $ (189,309)
Beginning balance (in shares) at Mar. 31, 2026                 15,436,224
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for settlement of equity awards (in shares)       162,664          
Issuance of common stock for settlement of equity awards 0     $ 2   (2)      
Shares withheld related to net share settlement (in shares)       (30,625)          
Shares withheld related to net share settlement (191)     $ (1)   (190)      
Stock-based compensation expense 3,187         3,187      
Net income 21,969           21,969    
Other comprehensive income (loss) (85)             (85)  
Ending balance (in shares) at Jun. 30, 2026   36,646,204 55,032,694 52,082,428 55,032,694        
Ending balance at Jun. 30, 2026 $ 299,845     $ 521 $ 550 $ 751,941 $ (228,326) $ (35,532) $ (189,309)
Ending balance (in shares) at Jun. 30, 2026 15,436,224               15,436,224